SLP News and Press, Simulations Plus Inc. From 01/07/26

2026-01-07 17:35:21 ET More on Simulations Plus Simulations Plus: Solid Platform, Soft Outlook (Rating Upgrade) Simulations Plus: Buying On Long-Term Silico Drug-Development Simulations Plus, Inc. 2025 Q4 - Results - Earnings Call Presentation Simulations Plu...

Driving Growth with Integrated Software, Services, and AI-Enabled Ecosystem Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovatio...

Conference call to be on Thursday, January 8, 2026, at 5 p.m. ET Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced th...

Validated engines and AI-orchestrated ecosystem align with the emerging regulatory framework Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances bi...

2025-12-09 03:31:39 ET Simulations Plus' ( SLP ) fourth-quarter results were soft but in line with expectations. While the initial share price response was positive, the stock quickly lost momentum, which likely stems from the fact that Simulations Plus' revenue guidance implies gro...

2025-12-04 12:50:00 ET While modeling and simulation software provider Simulations Plus (NASDAQ: SLP) reported mixed results for the fourth quarter of fiscal 2025, the company's outlook for fiscal 2026 was enough to propel the stock higher. Simulations Plus stock had gained 21.6% fo...

2025-12-02 21:41:59 ET ... Read the full article on Seeking Alpha For further details see: Simulations Plus: Buying On Long-Term Silico Drug-Development

2025-12-02 15:40:07 ET Simulations Plus (NASDAQ: SLP) was a popular niche stock on the exchange on Tuesday. The healthcare tech specialist's equity was rising by over 16% in late-session trading, thanks to a fresh earnings report that many investors found quite encouraging. ...

2025-12-01 20:14:33 ET More on Simulations Plus Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery Simulations Plus, Inc. (SLP) Presents At Morgan Stanley 23rd Annual Global He...

2025-12-01 20:13:24 ET Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call December 1, 2025 5:00 PM EST Company Participants Shawn O'Connor - Chief Executive Officer William Frederick - EVP & CFO Conference Call Participants Lisa Fortuna Jeffre...